-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.50127.82% Upside
Achieve Life Sciences, Inc. Frequently Asked Questions
-
What analysts cover Achieve Life Sciences, Inc.?
Achieve Life Sciences, Inc. has been rated by research analysts at Oppenheimer, Maxim Group in the past 90 days.